pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Obesity · news · pharmadog
← back to Obesity
News mentioning Obesity
737
stories
Jun 9, 26
STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
stat
Jun 8, 26
Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
stat
Jun 8, 26
#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six months
endpoints
Jun 8, 26
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
stat
Jun 8, 26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
biopharma dive
Jun 8, 26
STAT+: Novo underwhelmed by drug it once fought Pfizer for
stat
Jun 8, 26
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
stat
Jun 8, 26
#ADA26: Novo Nordisk targets 2030 launch for triple-G obesity shot
endpoints
Jun 8, 26
STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
stat
Jun 8, 26
Major readouts from the annual diabetes conference
stat
Jun 8, 26
STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
stat
Jun 8, 26
Opinion: American horses are obese, too
stat
Jun 8, 26
Opinion: $2 million gene therapy cures require a financing model
stat
Jun 7, 26
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
stat
Jun 7, 26
#ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effects
endpoints
Jun 7, 26
STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drug
stat
Jun 6, 26
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
stat
Jun 6, 26
STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
stat
Jun 6, 26
#ADA26: Pfizer's monthly shot shows effect on obesity, diabetes
endpoints
Jun 6, 26
STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential
stat
Jun 6, 26
#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year
endpoints
Jun 5, 26
Texas AG investigating energy drinks
stat
Jun 4, 26
What RevMed’s pancreatic cancer drug meant for one patient
stat
Jun 4, 26
Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic
endpoints
Jun 4, 26
Male puberty is understudied — but when it starts may predict long-term health risks
stat
Jun 3, 26
NewLimit’s $435M megaround; Lilly’s busy dealmaking week
biopharma dive
Jun 3, 26
STAT+: Legend Biotech emerged as a rare market winner
stat
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 3, 26
Is the military fueling eating disorders?
stat
Jun 3, 26
Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
stat
← prev
page 21 of 25
next →